ABSTRACT Background: Dietary intake is known to influence glucose metabolism, but there is little consensus on the optimal distribution of macronutrient intakes during pregnancy to prevent gestational diabetes (GDM). Objective: We aimed to investigate whether macronutrient intake distribution during the second trimester of pregnancy was associated with glucose metabolism later in pregnancy. Design: Women with singleton pregnancies and without preexisting type 1 or type 2 diabetes were included. Participants underwent a 3-h oral-glucose-tolerance test at 30 wk (95% CI: 25, 33 wk) gestation and were asked to recall their second-trimester dietary intake by using a validated food-frequency questionnaire. Results: Of the 205 participants, 47 (22.9%) had a diagnosis of GDM. A higher intake of saturated fat (b 6 SEE: 0.059 6 0.021; P = 0.005) and trans fat (0.381 6 0.145; P = 0.009) as a percentage of energy and of added sugar (0.017 6 0.007; P = 0.02) and a lower intake of vegetable and fruit fiber (20.026 6 0.012; P = 0.03) were individually associated with increased fasting glucose after multiple adjustment. In participants with a family history of type 2 diabetes, a higher vegetable and fruit fiber intake was associated with reduced insulin resistance (20.100 6 0.029; P = 0.0008) and increased insulin sensitivity (0.029 6 0.012; P = 0.01), after similar adjustment. An increased risk (OR per 1-SD change) of GDM was associated with lower carbohydrate (0.60; 95% CI: 0.40, 0.90) and higher total fat (1.61; 95% CI: 1.06, 2.44) intakes as a percentage of energy, after similar adjustment. Conclusions: Macronutrient intake during the second trimester of pregnancy was associated with a risk of abnormal glucose metabolism later in pregnancy. This finding supports the need for continued work to determine optimal prenatal nutritional strategies to prevent GDM. This trial is registered at clinicaltrials.gov as NCT01405547.
INTRODUCTION
Changes in carbohydrate and lipid metabolism occur during pregnancy to support the fetus and to prepare maternal organs for delivery and lactation (1) . Although insulin sensitivity deteriorates in normal pregnancy (2) , most women are able to maintain normoglycemia (1) . These changes in insulin sensitivity, however, are deleterious on a background of b cell dysfunction in the 4-18% of pregnant women who develop GDM 4 (3) (4) (5) . Women with GDM and their offspring are at increased risk of not only adverse pregnancy outcomes, including macrosomia and cesarean delivery, but also long-term adverse health outcomes, including the future development of type 2 diabetes (5) (6) (7) (8) . Therefore, it would be of considerable interest to prevent GDM. Evidence from observational studies and clinical trials indicates that dietary intake influences glucose metabolism (9) . Randomized clinical trials that implemented a low-fat and high-carbohydrate diet as part of an overall lifestyle intervention successfully reduced the risk of developing type 2 diabetes (10, 11) . In addition, higher trans fat and lower polyunsaturated fat intakes have been associated with risk of type 2 diabetes (12), whereas higher dietary fiber intake has been linked with improved insulin sensitivity (13) (14) (15) .
The American Diabetes Association and the American Congress of Obstetricians and Gynecologists recommend individualized nutritional therapy for metabolic management during pregnancy and provide no specific guidance on the optimal macronutrient distributions to manage GDM (16, 17) . The Canadian Diabetes Association recommends consuming ,35% of energy from fat and 45-60% from carbohydrate for diabetes management in general (6) , whereas others suggest higher fat (40%) and lower carbohydrate (,40%) intakes for women with GDM (18) .
In addition to a lack of specific dietary guidelines for the management of GDM, evidence regarding optimal prenatal nutrition to prevent GDM has been limited (19, 20) . Substituting dietary fat for carbohydrate during the second trimester in one study was associated with increased GDM risk (19) , whereas the first-trimester dietary intake distributions of fat and carbohydrate were not associated with GDM in another study (20) . Women in a recent study who developed GDM were shown to consume a higher saturated fat and lower polyunsaturated fat intake during pregnancy (21) , but the effect of other macronutrients was not reported.
Because women with GDM and their offspring are at increased risk of adverse pregnancy outcomes and chronic disease development later in life (5) (6) (7) (8) , it is important to clarify the role of prenatal nutrition in the prevention of GDM. Only a few studies have investigated the effect of diet during pregnancy on risk of GDM (19, 20, 22) , and none have studied this issue with the use of comprehensive glucose homeostasis profiles. After comprehensive assessment of diet and metabolic status, we hypothesized that macronutrient intake distribution in the second trimester of pregnancy would be associated with glucose metabolism (ie, GDM status, hyperglycemia, insulin resistance and sensitivity, and b cell function) later in pregnancy.
SUBJECTS AND METHODS

Study design
Between March 2009 and July 2010, pregnant women were recruited in outpatient clinic waiting areas at Mount Sinai Hospital (Toronto, Canada)-a large tertiary care center where .7000 pregnancies are followed annually (23) . The inclusion criterion for the current investigation was women aged 20 y carrying singleton pregnancies. Women who reported preexisting type 1 or type 2 diabetes, current use of insulin, or completion of an OGTT during the current pregnancy were excluded. Signed informed consent was obtained from all participants, and the study was approved by the Mount Sinai Hospital Research Ethics Board.
Standard obstetrical practice in Canada involves universal screening for GDM in all pregnant women at 24-28 wk of gestation with a GCT, wherein the plasma glucose concentration is measured 1 h after ingestion of a 50-g glucose load (6) . If a plasma glucose concentration is 7.8 mmol/L, the patient is referred for a diagnostic OGTT, in which plasma glucose concentrations are measured while fasting and then hourly for 3 h after ingestion of 100 g glucose. In clinical practice, an OGTT would typically only be ordered if the results of a GCT were abnormal. In this study, however, all participating women were asked to have an OGTT regardless of the results of a GCT. Of 199 participants with GCT data, 52 (26.1%) had a normal GCT result (,7.8 mmol/L) and 147 (73.9%) had an abnormal GCT result (7.8 mmol/L). GDM was diagnosed on the basis of the OGTT in 1 of 52 (1.9%) participants with a normal GCT result and in 44 of 147 (29.9%) participants with an abnormal GCT result. According to standard practice, women with a positive GCT result, or with a higher risk of GDM (6), were not provided with additional dietary advice in the study hospital until GDM was diagnosed on the basis of a positive OGTT result.
After the inclusion and exclusion criteria were applied, a total of 205 women who completed an OGTT at 30 (95% CI: 25, 33) wk of gestation were included in the current analysis. Gestational age was determined by using the self-reported date of the last menstrual period or first-trimester ultrasound assessment.
Outcome assessments
Participating women underwent a 3-h 100-g OGTT at 30 (95% CI: 25, 33) wk of gestation, during which blood samples were drawn at fasting and 30, 60, 120, and 180 min after the glucose load. Glucose was measured by using the hexokinase enzymatic method (Roche Modular Analytics E170). Insulin was measured by using the Elecsys 1010 (Roche Diagnostics) immunoassay analyzer and electrochemiluminescence immunoassay.
GDM was diagnosed in women who met 2 of the following criteria of the National Diabetes Data Group (24): fasting glucose 5.8 mmol/L, 1-h blood glucose 10.6 mmol/L, 2-h blood glucose 9.2 mmol/L, or 3-h blood glucose 8.1 mmol/L. The total AUCglu during the OGTT was calculated by using the trapezoidal rule. Insulin sensitivity was assessed by using the ISogtt, which is an established measure of whole-body insulin sensitivity that has been validated against the euglycemichyperinsulinemic clamp (25) . ISogtt was defined as follows:
where FPG is fasting plasma glucose, FPI is fasting plasma insulin, G is mean glucose during the OGTT, and I is mean insulin (25) . HOMA-IR, which is a measure of insulin sensitivity (primarily hepatic), was calculated as FPG · FPI/22.5 (26) . b Cell function was estimated by using 2 different methods: 1) the insulinogenic index/HOMA-IR was calculated as the ratio of the incremental change in insulin during the first 30 min of the OGTT to the incremental change in glucose over the same time period divided by HOMA-IR (27) , and 2) the ISSI-2 was defined as the product of insulin secretion measured by the ratio of the AUC for insulin to the AUCglu and insulin sensitivity measured by ISogtt (28) .
Dietary assessments
Dietary intake was collected by using an FFQ, which was originally developed by Block et al (29, 30) . The modified Block FFQ, designed to capture dietary intakes during specific trimesters of pregnancy, was used in the current study to ask women to recall usual intake during the second trimester of pregnancy. The Block FFQ has been validated in several populations (31) , including pregnant women (19, 32) . The Block FFQ was also validated among women living in Ontario, Canada (33) . In the latter validation, the median deattenuated Pearson correlation coefficients between the FFQ and 24-h recalls were 0.44 for total energy, 0.46 for macronutrients, 0.73 for carbohydrate (% of energy), 0.61 for fat (% of energy), 0.41 for saturated fat, 0.53 for trans fat, 0.42 for polyunsaturated fat, 0.35 for monounsaturated fat, and 0.62 for total fiber (33) .
A paper copy of the FFQ was self-administered during the OGTT; therefore, the FFQ was completed before the diagnosis of GDM was determined. The participants were asked to recall their dietary intake during the second trimester of the current pregnancy, defined as 13-26 wk of gestation. Study personnel additionally provided the context of this time period for each participant before administration of the FFQ (eg, "your intake from the beginning of last March to the end of May"). A total of 193 of 205 participants (94.1%) who completed their OGTT at 26 wk of gestation were asked to recall their dietary intake during the entire second trimester of the current pregnancy. A total of 12 of 205 participants (5.9%) who completed their OGTT at 20-25 wk of gestation were asked to recall their dietary intake from 13 wk of gestation to the date of the OGTT.
Participating women were asked about the frequency and amount of each food and beverage item consumed. Eight frequency categories ranging from "never" to "every day" could be selected for most food items. The portion size consumed could be selected from a list of common food serving units, including the number of slices or by using photographs representing 3-dimensional bowl and plate portions ranging from 0.25 cups (59 mL) to 2 cups (474 mL). The questionnaire was designed to take ;30 min to complete. Study personnel checked for the completeness of each FFQ question during the study visit and reminded the participants to answer any unanswered questions. 
Other variables
Height and weight were measured at the time of the OGTT following standardized anthropometric protocols (35) , and selfreported pregravid weight was recorded. Questionnaires were administrated to obtain demographic, medical, physical activity, and smoking information. Family history of type 2 diabetes was defined as a history of type 2 diabetes in any extended biological relative, including parents, siblings, grandparents, aunts, uncles, and cousins. Socioeconomic status index was generated by using an occupational scale calibrated for the Canadian National Occupational Classification system (36) . Pregravid physical activity in the year before pregnancy was obtained by using the Baecke questionnaire, which has been validated in several populations, including women of childbearing age (37, 38) .
Statistical analysis
Distributions of continuous variables were assessed for normality, and natural log transformations of skewed variables were used in subsequent analyses. Descriptive statistics for continuous variables were summarized as means 6 SDs or medians (25th, 75th percentiles) for variables with a skewed distribution. Categorical variables were summarized as proportions. Baseline characteristics of subjects with and without GDM were compared by using Welch's modified t test or a chi-square test as appropriate.
General linear models were used to assess the associations of macronutrient intakes with continuous fasting glucose, AUCglu, HOMA-IR, log ISogtt, insulinogenic index/HOMA-IR, and ISSI-2. Multiple logistic regression analyses were conducted to evaluate associations of macronutrient intakes with GDM status. Potential covariates were considered if they were previously reported pregravid determinants of GDM (39) and/or found to be significantly different between those with and without GDM in univariate analysis. Each nutrient was tested separately in model 1 [adjusted for age, ethnicity (white and nonwhite), family history of diabetes (yes or no), and pregravid BMI (in addition to adjustment for daily intake of total energy for models testing cholesterol, fibers, and sugars)] and model 2 [adjusted as for model 1 plus gravid variables, including parity (0, 1, or 2), previous GDM (yes or no), pregnancy weight gain up to the time of the OGTT, and gestational weeks at the time of the OGTT]. Parity was included because multiparous women were more likely to be exposed to previous GDM than were nulliparous women. Gestational week at the time of the OGTT was included to account for variation in the timing of data collection. The ORs per 1-SD increase in the corresponding nutrient and 95% CIs were calculated.
To assess whether the predisposition to a family history of type 2 diabetes influences the associations of interest, macronutrient interactions with the family history of type 2 diabetes on metabolic status outcomes were assessed. This interaction testing was performed by adding an interaction term into a model adjusted for age, ethnicity (white and nonwhite), pregravid BMI, parity (0, 1, or 2), previous GDM (yes or no), pregnancy weight gain up to the OGTT, and gestational weeks at the time of the OGTT. For all statistical analyses, a 2-sided P value ,0.05 was considered to be statistically significant, except for interaction terms for which P , 0.01 was used to reduce the likelihood of false-positive interactions. All data analyses were performed by using SAS software (version 9.2; SAS Institute).
RESULTS
Characteristics of the participants with and without GDM are presented in Table 1 . GDM was diagnosed in 47 (22.9%) of 205 participants at 30 (95% CI: 25, 33) wk of gestation. Compared with women without GDM, women with GDM were more likely to have a family history of type 2 diabetes (P = 0.01); to have GDM in a previous pregnancy (P , 0.001); to have higher fasting glucose, AUCglu, fasting insulin, and HOMA-IR values; and to have a lower ISogtt, insulinogenic index/HOMA-IR, and ISSI-2 (all P 0.001) ( Table 1 ). The nonwhite ethnic group had a higher rate of GDM than did the white group (P = 0.04). A comparison of means showed that women with GDM consumed less energy, carbohydrate, and total sugar as a percentage of energy and more total fat, monounsaturated fat, and polyunsaturated fat as a percentage of energy during the second trimester of pregnancy (all P 0.03) ( Table 1) .
Assessment of macronutrients with hyperglycemia
Multiple regression models were constructed to assess the association of macronutrient intake with fasting glucose in Table 2 . A lower ratio of polyunsaturated to saturated fat; lower energy, carbohydrate, and vegetable and fruit fiber intakes; and higher total fat, saturated fat, and trans fat intakes as a percentage of energy and added sugar in coffee and tea were individually associated with increased fasting glucose (all P 0.04), after adjustment for pregravid covariates including age, ethnicity, family history of type 2 diabetes, and pregravid BMI (model 1). After additional adjustment for gravid covariates, including parity, previous GDM, pregnancy weight gain up to the OGTT, and gestational week at the time of the OGTT (model 2), the association of hyperglycemia with saturated fat and trans fat intakes as a percentage of energy, vegetable and fruit fiber intake, and added sugar remained significant (all P 0.03) ( Table 2) . Additional adjustment in model 2 for socioeconomic status index, pregravid physical activity index, or smoking status did not change the significant associations of fasting glucose with saturated fat and trans fat intakes as a percentage of energy, vegetable and fruit fiber intake, and added sugar (data not shown).
Statistical interactions of a family history of type 2 diabetes on the associations of fasting glucose with total fat, saturated fat, and trans fat as a percentage of energy were observed (all P-interaction 0.004). Subgroup analysis was performed according to a family history of type 2 diabetes. Because intakes of macronutrients with statistically significant interactions cannot be considered in isolation from other macronutrient intakes in clinical settings, carbohydrate intake as a percentage of energy, the ratio of polyunsaturated to saturated fat, and total fiber and vegetable and fruit fiber intakes were also included in the subgroup analysis ( Table 3 ). Higher intakes of total fat, saturated fat, and trans fat as a percentage of energy; a lower intake of carbohydrate as a percentage of energy; a lower ratio of polyunsaturatedto-saturated fat; and a lower intake of vegetable and fruit fiber were associated with hyperglycemia in participants with 4 Values are medians (25th, 75th percentiles); Welch's t test performed on log transformation. 5 Values are means (95% CIs); multiple regression performed by using a generalized linear model. a family history of type 2 diabetes after adjustment for pregravid and gravid covariates, but these macronutrients were not associated with hyperglycemia in those without a family history. Macronutrients were not significantly associated with AUCglu after adjustment for gravid and pregravid covariates (see Supplemental Table 1 under "Supplemental data" in the online issue). Subgroup analysis of macronutrients included in Table 3 , according to a family history of type 2 diabetes, was performed to understand the associations of these macronutrients with a different metabolic variable (ie, AUCglu) in women. AUCglu was associated with intakes of carbohydrate (b 6 SEE: 20.182 6 0.074; P = 0.02; P-interaction = 0.03), total fat (b 6 SEE: 0.195 6 0.083; P = 0.02; P-interaction = 0.03), and saturated fat (b 6 SEE: 0.615 6 0.180; P = 0.0009; P-interaction = 0.0007) as a percentage of energy in those with a family history of type 2 diabetes after adjustment for pregravid and gravid covariates, but no significant association was observed in those without a family history of type 2 diabetes.
When a regression analysis for macronutrient intakes with fasting glucose was stratified by GDM status, the directions of the associations were similar to those observed for the entire sample population, except for added sugar (see Supplemental Table 2 under "Supplemental data" in the online issue). Added sugar intake was associated with fasting glucose only in those without GDM (b 6 SEE: 0.020 6 0.007; P = 0.006). 3 Adjusted as for model 1 plus parity (0, 1, or 2), previous gestational diabetes, pregnancy weight gain up to the time of the oral-glucose-tolerance test, and gestational week at the time of the oral-glucose-tolerance test.
4 P:S ratio, ratio of polyunsaturated to saturated fatty acids. 5 Additionally adjusted for daily intake of energy (kcal). 
Assessment of macronutrients with insulin resistance and sensitivity
Macronutrient variables were not associated with insulin resistance assessed on the basis of HOMA-IR (see Supplemental  Table 3 under "Supplemental data" in the online issue), except for vegetable and fruit fiber intake, which was associated with HOMA-IR after adjustment for pregravid and gravid covariates (b 6 SEE: 20.059 6 0.021; P = 0.005). In Table 4 , the participating women were stratified by a family history of type 2 diabetes. A lower vegetable and fruit fiber intake was associated with increased HOMA-IR in those with a family history of diabetes after adjustment for pregravid and gravid covariates, but the association was not observed in those without a family history of diabetes (Table 4) .
Macronutrient compositions were not associated with insulin sensitivity assessed on the basis of ISogtt after adjustment for pregravid and gravid covariates (see Supplemental Table 3 under "Supplemental data" in the online issue). Of those with a family history of type 2 diabetes, a higher vegetable and fruit fiber intake was associated with a higher ISogtt after adjustment for the pregravid and gravid covariates in Table 5 . In those without a family history of diabetes, higher intakes of total fat and saturated fat as a percentage of energy were associated with increased insulin sensitivity ( Table 5) .
Assessment of macronutrients with the b cell function
Macronutrients were not associated with the b cell function (assessed on the basis of insulinogenic index/HOMA-IR and ISSI-2) after adjustment for pregravid and gravid covariates (see Supplemental Table 4 under "Supplemental data" in the online issue). No statistical interaction was observed between macronutrients and the b cell function assessed on the basis of either insulinogenic index/HOMA-IR or ISSI-2 (see Supplemental  Table 4 under "Supplemental data" in the online issue). 
Assessment of macronutrient with the GDM outcome
Multiple logistic regression models were constructed to assess whether dietary variables were associated with GDM. Lower intakes of carbohydrate and higher intakes of total fat and monounsaturated fat as a percentage of energy were individually associated with GDM after adjustment for pregravid covariates ( Table 6) . When the models were additionally adjusted for gravid covariates (Table 6) , GDM remained significantly associated with lower carbohydrate (OR per 1-SD change: 0.60; 95% CI: 0.40, 0.90) and higher total fat (OR per 1-SD change: 1.61; 95% CI: 1.06, 2.44) intake distributions as a percentage of energy, whereas the association of monounsaturated fat intake as a percentage of energy was attenuated to nonsignificance (Table 6) . Additional adjustment of model 2 for socioeconomic status index, pregravid physical activity index, or smoking status did not change the significant association of GDM with intakes of carbohydrate and total fat as a percentage of energy (OR effect size change: ,2% for each model; data not shown). No statistical interactions of dietary variables with a family history of type 2 diabetes on GDM status were observed (data not shown).
DISCUSSION
Dietary intake distributions higher in total fat and lower in carbohydrate during the second trimester of pregnancy were associated with an increased risk of GDM later in pregnancy after adjustment for potential pregravid and gravid confounders. Higher saturated and trans fat intakes as a percentage of energy and added sugar and lower vegetable and fruit intakes were individually associated with hyperglycemia after similar adjustment. In those with a family history of type 2 diabetes, higher vegetable and fruit fiber intakes were associated with reduced insulin resistance and increased insulin sensitivity later in pregnancy after similar adjustment. Distributions of macronutrients consumed during the second trimester of pregnancy, however, were not associated with b cell function later in pregnancy.
Previously, the Pregnancy, Infection, and Nutrition Study reported that substituting fat for carbohydrate (per each 1% of total energy) during the second trimester resulted in an increased relative risk of GDM of 1.1 (95% CI: 1.02, 1.10) (19) . The authors further showed that a macronutrient intake distribution of 30% fat and 50% carbohydrate resulted in an almost 50% reduction in the predicted probability of GDM compared with a distribution of 40% fat and 40% carbohydrate (19) . However, in Project Viva, another cohort study conducted in the United States, distributions of dietary fat and carbohydrate intakes in early pregnancy were not associated with GDM (20) . In this study, the authors used a FFQ to assess dietary intakes from the time of conception (last menstrual period) to a mean of 12 wk of gestation (20, 40) . The dietary intake reported in Project Viva, therefore, reflected the diet during the first trimester of pregnancy, whereas the Pregnancy, Infection, and Nutrition study captured intake during the second trimester. It is possible that the inconsistent findings of these studies might be explained by differences in the effect of diet on GDM risk according to trimester. It must also be noted that the metabolic effects of substituting fat for carbohydrate are complex, because different types of fat and carbohydrate may have different effects on glucose metabolism (9) .
In addition to the association of total dietary fat with an increased risk of glucose intolerance (9), dietary fat composition, including higher trans fat and lower polyunsaturated fat, has been individually associated with the risk of type 2 diabetes (12). In pregnancy, diets higher in saturated fat and lower in polyunsaturated fat and in the ratio of polyunsaturated to saturated fat have been individually associated with glucose intolerance (21, 22, 41) . Similarly to our results, a higher saturated fat intake was associated with a higher fasting insulin concentration during pregnancy, after adjustment for BMI in a study from Northern Italy (22) . In a randomized controlled dietary intervention study of 162 men and women aged 30-65 y (42), insulin sensitivity was significantly reduced in those who received a diet consisting of 17% saturated fat and 37% total fat for 3 mo. Our results, however, indicated that slightly higher fat intakes as a percentage of energy might improve insulin sensitivity in those without a family history of type 2 diabetes, whereas this association was not observed in those with a family history of diabetes. In addition, the postprandial glucose response assessed on the basis of AUCglu was significantly associated with carbohydrate, total fat, and saturated fat intakes as a percentage of energy in those with a family history of diabetes, whereas this association was not observed in those without a family history of diabetes. Therefore, it is possible that the distribution of macronutrient intakes during pregnancy may have different metabolic effects in healthy women without a family history of diabetes than in those who are predisposed to diabetes because of a positive family history. Dietary fiber intake is known to reduce the postprandial glucose response (14) . Many prospective cohort studies have reported a reduced risk of developing type 2 diabetes in individuals who consumed higher intakes of total fiber (43) (44) (45) and cereal fiber (43, 44, 46) . In the Nurses' Health Study II, women with lower total, cereal, and fruit fiber intakes were at increased risk of GDM (47) . The mechanism by which dietary fiber may affect glucose intolerance is not entirely clear. Intervention studies using the euglycemic-hyperinsulinemic clamp technique have shown that insulin sensitivity was higher in individuals who received a high-fiber treatment lasting 4-6 wk (13, 15) . Insulin resistance assessed on the basis of HOMA-IR was also lower in those with higher fiber intakes (13) . Therefore, improved insulin sensitivity might be an important mechanism whereby a higher fiber intake might influence glucose metabolism and subsequently reduce the development of diabetes.
We, however, cannot exclude the possibility that our observed associations of vegetable and fruit fiber intake with insulin sensitivity might have been confounded by other components in vegetables and/or fruit. Our lack of association between grain fiber and metabolic status during pregnancy could also be attributed to a lack of variation in grain fiber intakes in our study participants. Similarly, a lack of significant associations of macronutrients with postprandial glucose response or insulin resistance in those without a family history of diabetes might be attributed to a narrower degree of variation in metabolic variables in women in this subgroup. It is possible that logistic regression, which assessed the dichotomous outcome (with or without GDM), might have been underpowered to assess a small effect change in saturated and trans fat intakes as a percentage of energy, vegetable and fruit fiber intake, and added sugar intake that the continuous outcome variable (ie, fasting glucose) was able to detect. In addition, we were unable to further investigate potential ethnic-specific eating habits in relation to metabolic responses because of our small sample size and lack of detailed information on ethnic origin. Another methodologic limitation of our study was potential underreporting of dietary intake. It has been documented that overweight and obese individuals are more likely to underreport dietary intakes (48, 49) . We used energyadjusted intakes to assess associations between diet and metabolic status to minimize the potential effect of underreporting. However, the methodologic influence of underreporting might have reduced our reported effect sizes by narrowing the difference between those with normal and those with abnormal glucose metabolism. Because our pregravid BMI was calculated by using measured height and self-reported pregravid weight, overweight and obese women might have also underreported pregravid weight (50) . According to the standard practices of our study hospital, dietary advice is not provided to women with a positive GCT or with a higher risk of GDM (6), but we cannot rule out the possibility that women with an abnormal GCT may have independently altered their dietary intakes between the GCT and OGTT. If women took the initiative to change their dietary intake, it would have had a minimal effect on the assessed dietary intakes between 13 and 26 wk of gestation, because an average wait period between the GCT and OGTT is only 2 wk and most of our study participants would likely have completed the GCT at 26 wk of gestation (as 87.3% completed the OGTT at 28 wk of gestation). The strength of our study was that we were able to assess the detailed macronutrient intake distributions during a clearly defined trimester of pregnancy and to study their associations with the detailed glucose metabolic profile.
The clinical practice guidelines for optimal macronutrient distributions to manage or prevent GDM have not been established. In addition to limited evidence regarding optimal prenatal nutrition to prevent GDM (19, 20) , no previous studies have used a comprehensive set of glucose homeostasis indicators. In the current study, comprehensive assessments of diet during a clearly defined trimester of pregnancy and detailed assessments of the glucose metabolic profile-including GDM status, hyperglycemia, insulin resistance and sensitivity, and b cell function-macronutrient intake during the second trimester of pregnancy was associated with a risk of abnormal glucose metabolism later in pregnancy. Our results add to growing knowledge of the importance of nutrition during pregnancy on the metabolic health of women and emphasize the need for continued work to determine optimal prenatal nutritional strategies to prevent GDM.
